(firstQuint)Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies.

 The objective of this exploratory study is to assess the benefits of memantine compared to placebo in out-patients with a diagnosis of Parkinson's Disease Dementia or Dementia with Lewy Bodies (mild to moderate severity) over a 6-month period.

 This is a multinational, randomised, double-blind, parallel-group, placebo-controlled, fixed-dose study with specific cognitive (attention, executive function, visual perception and memory), behavioural, functional and global measures.

.

 Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies@highlight

The purpose of this exploratory study is to determine whether memantine can provide benefits on clinical symptoms in patients with Parkinson's Disease Dementia or Dementia with Lewy Bodies.

